| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Francesca Antonelli, Antonio P Strafell. Behavioral disorders in Parkinson's disease: the role of dopamine. Parkinsonism & related disorders. vol 20 Suppl 1. 2014-07-11. PMID:24262157. |
in this review, we will summarize the possible proposed dopaminergic mechanisms responsible for these complications in pd, focusing mainly on the role of this neurotransmitter in behavioral symptoms. |
2014-07-11 |
2023-08-12 |
Not clear |
| Janine Bayer, Pia Bandurski, Tobias Somme. Differential modulation of activity related to the anticipation of monetary gains and losses across the menstrual cycle. The European journal of neuroscience. vol 38. issue 10. 2014-07-08. PMID:23981052. |
estradiol and progesterone interact with the dopaminergic and other neurotransmitter systems that are involved in the processing of rewards. |
2014-07-08 |
2023-08-12 |
Not clear |
| J G Rahol. Antidepressants: pharmacological profile and clinical consequences. International journal of psychiatry in clinical practice. vol 5. issue 1. 2014-06-19. PMID:24936991. |
three neurotransmitter systems are implicated in the biological basis of depression: the serotonergic system is thought to be a major component in the development of depression and in the efficacy of antidepressant drugs, while the noradrenergic and dopaminergic systems play lesser roles, but are important in the development of antidepressant side-effects. |
2014-06-19 |
2023-08-13 |
Not clear |
| D Parkinson, A Spira, J P Wyse, M Patte. The ontogenesis of the dopaminergic cell in the pre- and postnatal guinea pig retina. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. vol 3. issue 2. 2014-06-02. PMID:24874597. |
although a significant degree of development of the dopaminergic neurotransmitter system in the guinea pig occurs before birth the attainment of a fully mature system postnatally may require normal photic stimulation of physiologic activity. |
2014-06-02 |
2023-08-13 |
Not clear |
| Sebastian Puschmann, André Brechmann, Christiane M Thie. Learning-dependent plasticity in human auditory cortex during appetitive operant conditioning. Human brain mapping. vol 34. issue 11. 2014-05-28. PMID:22610479. |
in addition, learners showed similar learning-induced differential responses to reward-predicting and nonreward-predicting tones in the ventral tegmental area and the nucleus accumbens, two core regions of the dopaminergic neurotransmitter system. |
2014-05-28 |
2023-08-12 |
human |
| Prachi Kukshal, Venkat Chowdari Kodavali, Vibhuti Srivastava, Joel Wood, Lora McClain, Triptish Bhatia, A M Bhagwat, Smita Neelkanth Deshpande, Vishwajit Laxmikant Nimgaonkar, B K Thelm. Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort. Journal of psychiatric research. vol 47. issue 11. 2014-05-13. PMID:23932573. |
associations of polymorphisms from dopaminergic neurotransmitter pathway genes have mostly been reported in caucasian ancestry schizophrenia (sz) samples. |
2014-05-13 |
2023-08-12 |
Not clear |
| Iñaki-Carril Mundiñano, Maria Hernandez, Carla Dicaudo, Cristina Ordoñez, Irene Marcilla, Maria-Teresa Tuñon, Maria-Rosario Luqui. Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys. Acta neuropathologica. vol 126. issue 3. 2014-04-07. PMID:23784261. |
olfactory bulb (ob) pathology in these diseases shows an increased number of olfactory dopaminergic cells, protein aggregates and dysfunction of neurotransmitter systems. |
2014-04-07 |
2023-08-12 |
human |
| Lars Brichta, Paul Greengard, Marc Flajole. Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems. Trends in neurosciences. vol 36. issue 9. 2014-04-02. PMID:23876424. |
novel pharmacological strategies must be optimized for pd by: (i) targeting disturbances of the serotonergic, noradrenergic, glutamatergic, gabaergic, and cholinergic systems in addition to the dopaminergic system, and (ii) characterizing alterations in the levels of neurotransmitter receptors and transporters that are associated with the various manifestations of the disease. |
2014-04-02 |
2023-08-12 |
Not clear |
| Phillip L Pear. Monoamine neurotransmitter deficiencies. Handbook of clinical neurology. vol 113. 2014-03-27. PMID:23622404. |
there are therapeutic roles for neurotransmitter supplementation, and dopaminergic agonists. |
2014-03-27 |
2023-08-12 |
Not clear |
| Jhodie Rubina Duncan, Andrew John Lawrenc. Conventional concepts and new perspectives for understanding the addictive properties of inhalants. Journal of pharmacological sciences. vol 122. issue 4. 2014-03-27. PMID:23883487. |
however, growing evidence suggests that the reinforcing properties of inhalants may also be driven by their ability to affect neurotransmitter systems other than the dopaminergic system. |
2014-03-27 |
2023-08-12 |
Not clear |
| Yannick Vermeiren, Nathalie Le Bastard, An Van Hemelrijck, Wilhelmus H Drinkenburg, Sebastiaan Engelborghs, Peter P De Dey. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia. Alzheimer's & dementia : the journal of the Alzheimer's Association. vol 9. issue 5. 2014-03-25. PMID:23159046. |
research suggests that altered activities of dopaminergic, serotonergic, (nor)adrenergic, as well as amino acid neurotransmitter systems play a role in the etiopathogenesis of bpsd. |
2014-03-25 |
2023-08-12 |
Not clear |
| Romain Meeusen, Bart Roelands, Lawrence L Sprie. Caffeine, exercise and the brain. Nestle Nutrition Institute workshop series. vol 76. 2014-02-13. PMID:23899750. |
caffeine also has an effect on the central nervous system (cns), and it is now recognized that most of the performance-enhancing effect of caffeine is accomplished through the antagonism of the adenosine receptors, influencing the dopaminergic and other neurotransmitter systems. |
2014-02-13 |
2023-08-12 |
Not clear |
| Peter R Joyce, John Stephenson, Martin Kennedy, Roger T Mulder, Patrick C McHug. The presence of both serotonin 1A receptor (HTR1A) and dopamine transporter (DAT1) gene variants increase the risk of borderline personality disorder. Frontiers in genetics. vol 4. 2014-01-16. PMID:24432029. |
dysfunction in the dopaminergic and serotonergic neurotransmitter systems has been demonstrated to be important in the etiology of borderline personality disorder (bpd). |
2014-01-16 |
2023-08-12 |
Not clear |
| Roger F Butterwort. Parkinsonism in cirrhosis: pathogenesis and current therapeutic options. Metabolic brain disease. vol 28. issue 2. 2013-12-16. PMID:23086199. |
the cause of parkinsonism in cirrhosis has been attributed to manganese deposition in basal ganglia structures, leading to the dysfunction of the dopaminergic neurotransmitter system. |
2013-12-16 |
2023-08-12 |
Not clear |
| Eric Promme. Olanzapine: palliative medicine update. The American journal of hospice & palliative care. vol 30. issue 1. 2013-12-03. PMID:22495793. |
olanzapine blocks multiple neurotransmitter receptors, including dopaminergic (d(1), d(2), d(3), and d(4)), serotonergic (5-hydroxytryptamine 2a [5-ht(2a)], 5-ht(2c), 5-ht(3), and 5-ht(6)), adrenergic (α(1)), histaminic (h(1)), and muscarinic (m(1), m(2), m(3), and m(4)) receptors. |
2013-12-03 |
2023-08-12 |
Not clear |
| S K Bhattacharya, P J Rao, S J Brumleve, S S Parma. Role of putative neurotransmitters in bradykinin-induced catalepsy in the rat. Pharmaceutical research. vol 3. issue 3. 2013-11-26. PMID:24271522. |
further, the recent report from this laboratory that centrally administered bradykinin specifically augments rat brain prostaglandin e2 levels, together with the proposed role of central prostaglandins as modulators of central synaptic transmission, suggests that bradykinin-induced catalepsy is mediated and modulated through pge effects on serotonergic, cholinergic, and dopaminergic neurotransmitter systems. |
2013-11-26 |
2023-08-12 |
rat |
| Gammon M Earhart, Michael J Falv. Parkinson disease and exercise. Comprehensive Physiology. vol 3. issue 2. 2013-11-19. PMID:23720332. |
pd is now thought to be a multisystem disorder that involves not only the dopaminergic system, but other neurotransmitter systems whose role may become more prominent as the disease progresses (189). |
2013-11-19 |
2023-08-12 |
human |
| Roji Thomas, Andrea E Cavann. The pharmacology of Tourette syndrome. Journal of neural transmission (Vienna, Austria : 1996). vol 120. issue 4. 2013-10-25. PMID:23361655. |
converging evidence from different lines of research suggests that the pathophysiology of ts involves altered dopaminergic transmission in the cortico-striatal-thalamo-cortical circuits, along with other neurotransmitter systems. |
2013-10-25 |
2023-08-12 |
Not clear |
| Y C Wu, R A Hill, A Gogos, M van den Buus. Sex differences and the role of estrogen in animal models of schizophrenia: interaction with BDNF. Neuroscience. vol 239. 2013-10-17. PMID:23085218. |
major neurotransmitter systems including dopaminergic, serotonergic and glutamatergic pathways are modulated and supported by estrogen and bdnf. |
2013-10-17 |
2023-08-12 |
Not clear |
| Laura Stappert, Lodovica Borghese, Beate Roese-Koerner, Sandra Weinhold, Philipp Koch, Stefanie Terstegge, Markus Uhrberg, Peter Wernet, Oliver Brüstl. MicroRNA-based promotion of human neuronal differentiation and subtype specification. PloS one. vol 8. issue 3. 2013-09-27. PMID:23527072. |
we further show that mir-125b and mir-181a specifically promote the generation of neurons of dopaminergic fate, whereas mir-181a inhibits the development of this neurotransmitter subtype. |
2013-09-27 |
2023-08-12 |
human |